Deals
GCP, a provider of blended equity and debt to the UK’s small to medium sized businesses, has invested in Iglu.com, an online ski and cruise agent, in a deal valued at GBP19 million, to help the business expand into Europe.
GCP is taking a significant minority stake in the business and will join the existing board. GCP underwrote the entire transaction, providing the debt and equity on the deal that was a buyout from Matrix Private Equity Partners.
Simon Jobson, partner at GCP, says: “Iglu has capitalised brilliantly on the huge increase in the popularity of online travel, especially in
Dunedin the UK mid-market buyout house has sold Capula to Dutch quoted company, Imtech. This is the second exit for Dunedin within ten days following the sale of WFEL to KMW, a German land defence systems provider. Under Dunedin’s ownership both businesses have seen significant growth, attracting a number of bids from overseas buyers.
Capula, the UK’s market leading independent provider of IT systems that control operations and real time information at power stations, nuclear facilities and water networks has reported record order intakes under Dunedin’s ownership, of over GBP75 million in the last two years. Since Dunedin’s initial investment
Clairvue Capital Partners has completed investing Clairvue Capital Partners Fund I, a USD200 million fund launched in April, 2010.
According to Jeff Giller, Managing Partner and Chief Investment Officer: “The preponderance of Clairvue I’s capital was invested in real estate vehicle recapitalisations where the proceeds advanced by Clairvue were used to help resolve debt maturity issues and other capital needs. The seven investments in Clairvue I’s portfolio create broad diversification with exposure to assets located throughout the United States and Europe, to office, retail, industrial, hotel and multi-family property types, to vehicles with vintage years from 2004 through 2008, and
Affiliates of GS Capital Partners and P2 Capital Partners, LLC (are to acquire Interline Brands for USD25.50 per share in cash.
The transaction, which has been unanimously approved by Interline’s board of directors, is valued at approximately USD1.1 billion, including the assumption of debt. The price of USD25.50 per share represents a premium of approximately 42% relative to the Company’s closing stock price on 25 May, 2012, the last trading day before the announcement of the transaction, and a 31% premium relative to the Company’s trailing 30-day average closing stock price.
"This agreement provides excellent value to shareholders. This is
Exosun, a company specialising the design, construction and maintenance of ground solar power plants equipped with trackers, has completed a second fundraising operation worth EUR12 million intended to support its growth and strengthen its financial structure.
Omnes Capital (formerly Crédit Agricole Private Equity), which owns a stake in Exosun since 2009, participated in the roundtable alongside new partners: ADEME (French environment and energy management agency), which has undertaken its first investment since it received the mandate to invest directly in cleantech industry firms as part of the French government initiative “Investments for the Future”; Grand Sud Ouest Capital and Aquitaine
NXT Capital has increased its total debt financing capacity to USD1.6 billion and expanded its senior secured revolving credit facility from USD650 million to USD740 million.
Agented by Wells Fargo Bank, NA and affiliates, this facility provides funding for NXT’s middle-market senior secured commercial loan portfolio. The increase in size comprised commitments of USD50 million from Capital One Bank and USD40 million from EverBank Commercial Finance (“EverBank”), who now join Co-Arranger SunTrust Bank, BMO Capital Markets Corp. and Key Corp. in NXT Capital’s bank group. In conjunction with this increase, NXT also received reduced pricing and an extension of the
Teralys Capital has made an investment of CAD65 million in TVM Life Science Ventures VII ("TVM LSV VII" or the "Fund"), which closed on an initial size of CAD150 million. The Fund will focus primarily on early stage drug development and life sciences company opportunities.
The investment by Teralys Capital, together with investments by Eli Lilly and Company (NYSE:LLY; "Lilly") and other partners, enables a new investment model in Québec, which will involve the formation by the Fund of single therapeutic asset companies and benefit the entire local life sciences ecosystem of researchers, entrepreneurs, business partners and service providers.
TVM
Lighting Science Group Corporation has completed the final round in a series of private placements totalling approximately USD140 million in equity funding and commitments, of which approximately USD88 million is new equity funding and commitments and approximately USD52 million represents the conversion of certain bridge financings occurring since the fourth quarter of 2011.
The proceeds from the new equity funding and commitments will be used to finance the Company’s growth, expand its manufacturing capabilities, and enhance its leadership position in developing innovative energy-efficient LED lighting products for consumer and commercial applications in both the public and private sectors. This new
Phoenix Equity Partners, a UK middle-market private equity firm, has invested in CloserStill, a business-to-business exhibition organiser, in a transaction which values the business at circa GBP25 million.
This is the sixth investment from Phoenix’s GBP450 million fund, which was raised in 2010, and is a partial exit for NVM Private Equity ("NVM"), which delivers an excellent return on their original investment.
Phoenix is backing the existing management team of CloserStill, led by Andy Center (CEO), Phil Soar (Chairman), Phil Nelson and Michael Westcott.
Phoenix’s investment, together with an ongoing investment by NVM, marks an exciting new phase in CloserStill’s
Cell Therapeutics has entered into an agreement to sell, subject to customary closing conditions, USD40 million of shares of its Series 15 Convertible Preferred Stock and warrants to purchase shares of its common stock (and the shares of common stock issuable from time to time upon conversion of the Series 15 Convertible Preferred Stock and exercise and exchange of the warrants) in a registered offering to an institutional accredited investor (the "Initial Purchaser") in two USD20 million tranches (the "Offering").
CTI plans to use the net proceeds from the Offering to finance the purchase price and related fees and expenses
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
